Advertisement

MSVirtual2020: ACTRIMS-ECTRIMS Latest

ECTRIMS

MS Virtual 2020: ECTRIMS-ACTRIMS eBook

Nov 18, 2020

ECTRIMS MS 2020v1.indd Featuring…. MS Relapses: In the Past? Ofatumumab Steps Closer...

ACTRIMS-ECTRIMS: Ofatumumab Shows Efficacy in New MS Patients

Oct 16, 2020
Functional potential of gut microbiome in paediatric MS

Oct 14, 2020
Gold nanocrystals may improve brain metabolic profile

Oct 14, 2020
Cardiovascular risk factors linked to brain atrophy in younger MS patients

Oct 14, 2020

Eculizumab reduces long-term relapse risk in AQP4+ NMOSD

Oct 14, 2020

Long-term efficacy and safety results of eculizumab monotherapy in patients with aquaporin-4 IgG-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) during the PREVENT trial and/or its ongoing open-label extension...

Gender-based approach to MS therapeutics: a missed opportunity

Oct 14, 2020
Predictive value of neurodegenerative CSF markers in MS

Oct 14, 2020
Amantadine, modafinil, and methylphenidate for MS-related fatigue

Oct 14, 2020
Management of PPMS and SPMS with approved DMT

Oct 14, 2020

Advertisement